Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses

Post-exposure vaccination with vaccinia virus (VACV) has been suggested to be effective in minimizing death if administered within four days of smallpox exposure. While there is anecdotal evidence for efficacy of post-exposure vaccination this has not been definitively studied in humans. In this stu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Holechek, Susan A., Denzler, Karen L., Heck, Michael C., Schriewer, Jill, Buller, R. Mark, Legrand, Fatema A., Verardi, Paulo H., Jones, Leslie A., Yilma, Tilahun, Jacobs, Bertram L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2013
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3798613/
https://ncbi.nlm.nih.gov/pubmed/24147092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0077879
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia